We are pleased to report that as of April 5th 2022, we have recruited 36 out of our target of 50 patients for the pilot and feasibility trial. This means that we are nearly three months ahead of schedule! It is testament to the hard work of the Principal Investigators at each of our three recruiting sites that we are doing so well and we are very grateful to all of the patients that have volunteered to take part.